Seeing Is Believing
Currently out of the existing stock ratings of Paul Knight, 121 are a BUY (94.53%), 7 are a HOLD (5.47%).
Analyst Paul Knight, currently employed at KEYBANK, carries an average stock price target met ratio of 51.8% that have a potential upside of 35.13% achieved within 146 days.
Paul Knight’s has documented 245 price targets and ratings displayed on 22 stocks. The coverage is on Healthcare, Basic Materials, Technology, Industrials sectors.
Most recent stock forecast was given on CSTL, Castle Biosciences at 05-Nov-2024.
Analyst best performing recommendations are on CYRX (CRYOPORT).
The best stock recommendation documented was for CYRX (CRYOPORT) at 1/19/2021. The price target of $75 was fulfilled within 3 days with a profit of $10.82 (16.86%) receiving and performance score of 56.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$145
$18.81 (14.91%)
$135
1 months 6 days ago
(15-Oct-2024)
5/9 (55.56%)
$0.42 (0.29%)
99
$145
$18.81 (14.91%)
$135
1 months 20 days ago
(01-Oct-2024)
4/4 (100%)
$-1.56 (-1.06%)
17
Hold
$147
$20.81 (16.49%)
$140
2 months 30 days ago
(22-Aug-2024)
6/6 (100%)
$6.78 (4.84%)
92
Buy
$200
4 months 25 days ago
(27-Jun-2024)
8/9 (88.89%)
$28.88 (16.88%)
196
Buy
$135
$8.81 (6.98%)
$146
5 months 18 days ago
(03-Jun-2024)
13/15 (86.67%)
$3.6 (2.74%)
403
Which stock is Paul Knight is most bullish on?
Which stock is Paul Knight is most reserved on?
What Year was the first public recommendation made by Paul Knight?